Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

Details for Australian Patent Application No. 2004260936 (hide)

Owner Abgenix, Inc.

Inventors Foord, Orit; Rathanaswami, Palani; Foltz, Ian; Klakamp, Scott L.; Green, Larry; Jia, Xiao-Chi; Raya, Robert; King, Chadwick T.; Keyt, Bruce; Feng, Xiao; Yang, Xiao Dong; Weber, Richard; Kang, Jaspal; Liu, Ying; Corvalan, Jose; Gudas, Jean; Su, Qiaojuan Jane

Agent Davies Collison Cave

Pub. Number AU-B-2004260936

PCT Pub. Number WO2005/012479

Priority 60/525,570 26.11.03 US; 60/483,145 27.06.03 US; 60/562,453 15.04.04 US

Filing date 25 June 2004

Wipo publication date 10 February 2005

Acceptance publication date 10 June 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/44 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/552 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/012479 Priority application(s): WO2005/012479

10 June 2010 Application Accepted

  Published as AU-B-2004260936

7 October 2010 Standard Patent Sealed

4 November 2010 Alteration of Name

  The name of the patentee has been altered to Amgen Fremont Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260937-Systems and methods for separating and concentrating regenerative cells from tissue

2004260935-Polymer encapsulation of adenoviruses